Accessibility Menu
Organogenesis Stock Quote

Organogenesis (NASDAQ: ORGO)

$4.11
(0.9%)
+0.04
Price as of October 22, 2025, 10:43 a.m. ET

KEY DATA POINTS

Current Price
$4.11
Daily Change
(0.9%) +$0.04
Day's Range
$4.05 - $4.15
Previous Close
$4.07
Open
$4.07
Beta
1.62
Volume
86,837
Average Volume
739,681
Market Cap
516.3M
Market Cap / Employee
$4.07M
52wk Range
$2.61 - $6.71
Revenue
-
Gross Margin
0.69%
Dividend Yield
N/A
EPS
-$0.12
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Organogenesis Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ORGO+30.87%+2.52%+0.5%-70%
S&P+15.06%+95.03%+14.29%+162%

Organogenesis Company Info

Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$101.01M-22.4%
Gross Profit$66.72M-31.0%
Gross Margin66.06%-8.1%
Market Cap$464.29M25.1%
Market Cap / Employee$0.53M0.0%
Employees8690.8%
Net Income-$9.39M44.9%
EBITDA-$3.96M-125.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$73.74M-18.5%
Accounts Receivable$120.38M13.6%
Inventory3322.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$31.05M-66.5%
Short Term Debt$9.77M-46.7%

Ratios

Q2 2025YOY Change
Return On Assets-1.82%1.9%
Return On Invested Capital8.11%5.6%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$36.51M-1377.5%
Operating Free Cash Flow-$32.87M-793.8%

Valuation

MetricQ4 2023Q1 2024Q4 2024YoY Change
Price to Earnings111.4465.44571.43-
Price to Book1.361.522.071.9143.20%
Price to Sales0.840.881.191.0830.57%
Price to Tangible Book Value1.601.792.452.2944.74%
Price to Free Cash Flow TTM55.0143.5798.49101.2723.06%
Enterprise Value to EBITDA31.1627.20-44.07-141.25-650.62%
Free Cash Flow Yield1.8%2.3%1.0%1.0%-18.74%
Return on Equity-2.7%0.3%-4.9%-2.6%-57.41%
Total Debt$106.38M$43.31M$42.63M$40.82M-63.22%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.